Genix Pharmaceuticals Corporation announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced net loss was CAD 488,451 compared to CAD 71,270 a year ago. Basic loss per share from continuing operations was CAD 0.01. For the nine months, net loss was CAD 1.283 million compared to CAD 155,594 a year ago. Basic loss per share from continuing operations was CAD 0.02.